Atlantic Union Bankshares Corp Acquires 526 Shares of Colgate-Palmolive (NYSE:CL)

Atlantic Union Bankshares Corp raised its holdings in Colgate-Palmolive (NYSE:CL) by 3.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,951 shares of the company’s stock after purchasing an additional 526 shares during the quarter. Atlantic Union Bankshares Corp’s holdings in Colgate-Palmolive were worth $1,268,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Amundi grew its stake in Colgate-Palmolive by 12.8% in the 4th quarter. Amundi now owns 9,200,144 shares of the company’s stock valued at $806,015,000 after purchasing an additional 1,040,604 shares during the period. Dorsey & Whitney Trust CO LLC grew its stake in Colgate-Palmolive by 3.5% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 17,163 shares of the company’s stock valued at $1,560,000 after purchasing an additional 582 shares during the period. Larson Financial Group LLC grew its stake in Colgate-Palmolive by 25.0% in the 4th quarter. Larson Financial Group LLC now owns 994 shares of the company’s stock valued at $90,000 after purchasing an additional 199 shares during the period. Intellectus Partners LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at $753,000. Finally, AMF Tjanstepension AB lifted its position in shares of Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after buying an additional 2,353,268 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $96.84 on Friday. The business’s 50-day moving average price is $88.84 and its two-hundred day moving average price is $95.17. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a market cap of $78.59 billion, a P/E ratio of 27.51, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company posted $0.87 EPS. As a group, equities analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analyst Ratings Changes

A number of research analysts have recently commented on CL shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. UBS Group dropped their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.